Contrast Media: NSF vs. CIN

Nephrogenic Systemic Fibrosis (NSF) versus Contrast-induced Nephropathy (CIN) is a user-friendly app designed by academic radiologists to help you choose the safest contrast agent (iodine or gadolinium) when imaging patients with renal impairment. It is an easy and convenient way to help healthcare professionals in their daily practices, including nurses, radiology technologists, medical students, interns, residents, clinicians, surgeons, oncologists, nephrologists, urologists, gastroenterologists, radiologists and other medical specialists.

Choosing the right agent for the right patient remains a challenge, and one should always weigh the risks and benefits of each option. This app provides a simple and practical approach to minimize the risk of developing NSF and CIN.

Chronic Kidney Disease (CKD)
MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) ?

Everything you need at your fingertips!

Features:
• Simple and user friendly.
• Estimates the risks of NSF and CIN after intravenous (IV) administration of contrast media (not intra-arterial injection!).
* Risk stratification and recommended action based on eGFR.
• An updated overview of nephrogenic systemic fibrosis (NSF) and contrast-induced nephropathy (CIN).
* No ads, subscriptions or in-app purchasing.
* No login or sign up required and no personal data collected from the user.

About the authors:

Sandro Fenelon, MD
Attending Radiologist, Abdominal Imaging Division
Sao Paulo State Cancer Institute (ICESP), University of Sao Paulo, School of Medicine, Department of Radiology and Oncology, Brazil

Frederico F. de Souza, MD
Director, Body Imaging Division
Assistant Professor of Radiology
University of Mississippi Medical Center, UMMC, USA

The U.S. FDA´s Regulation and Oversight of Mobile Medical Applications
* This app is NOT considered to be a medical device and FDA´s regulation is NOT applicable.